Search research articles
Contact Us
Filters
Showing results (391-400 of 404) with videos related to
Page
of 41
Sort By:
Nanomedicine (London, England)
|
June 17, 2017
<sup>68</sup>Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy
Penelope Bouziotis, Dimitris Stellas, Eloïse Thomas, et al.
Blood Cancer Journal
|
September 26, 2020
The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma
Maria Gavriatopoulou, Andriani Βoultadaki, Vassilis Koutoulidis, et al.
Diagnostic and Interventional Imaging
|
May 14, 2022
Comparison between 1.5-T and 3.0-T MRI for the diagnosis of placenta accreta spectrum disorders
Charis Bourgioti, Konstantina Zafeiropoulou, Chara Tzavara, et al.
Blood Cancer Journal
|
October 8, 2016
High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma
E Terpos, D Christoulas, E Kastritis, et al.
Radiology
|
February 27, 2019
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)
Christina Messiou, Jens Hillengass, Stefan Delorme, et al.
Journal of Clinical Medicine
|
April 12, 2025
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice
Ioannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, C Papadimitriou, U Dafni, et al.
Journal of Clinical Medicine
|
June 10, 2022
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients
Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group
M A Dimopoulos, C Bakoyannis, V Georgoulias, et al.
Journal of Bone Oncology
|
November 11, 2025
Bone disease burden does not impact overall survival in newly diagnosed patients with multiple myeloma - a single center, retrospective imaging analysis on 119 patients
Evangelos Terpos, Vassilis Koutoulidis, Ioannis Ntanasis-Stathopoulos, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 404) with videos related to
Sort By:
Page
of 41
Nanomedicine (London, England)
|
June 17, 2017
<sup>68</sup>Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy
Penelope Bouziotis, Dimitris Stellas, Eloïse Thomas, et al.
Blood Cancer Journal
|
September 26, 2020
The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma
Maria Gavriatopoulou, Andriani Βoultadaki, Vassilis Koutoulidis, et al.
Diagnostic and Interventional Imaging
|
May 14, 2022
Comparison between 1.5-T and 3.0-T MRI for the diagnosis of placenta accreta spectrum disorders
Charis Bourgioti, Konstantina Zafeiropoulou, Chara Tzavara, et al.
Blood Cancer Journal
|
October 8, 2016
High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma
E Terpos, D Christoulas, E Kastritis, et al.
Radiology
|
February 27, 2019
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)
Christina Messiou, Jens Hillengass, Stefan Delorme, et al.
Journal of Clinical Medicine
|
April 12, 2025
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice
Ioannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, C Papadimitriou, U Dafni, et al.
Journal of Clinical Medicine
|
June 10, 2022
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients
Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group
M A Dimopoulos, C Bakoyannis, V Georgoulias, et al.
Journal of Bone Oncology
|
November 11, 2025
Bone disease burden does not impact overall survival in newly diagnosed patients with multiple myeloma - a single center, retrospective imaging analysis on 119 patients
Evangelos Terpos, Vassilis Koutoulidis, Ioannis Ntanasis-Stathopoulos, et al.
Page
of 41